about the author

Endpoints Studio

studio@endpointsnews.com

Endpoints Studio is an internal design agency crafting impactful biopharma stories.

author articles

End­points we­bi­nar: In­side the “One Lon­za” strat­e­gy: Re-en­gi­neer­ing the fu­ture of CD­MO

Last month

END­POINTS WE­BI­NAR: CD­MOs’ crit­i­cal role in a rapid­ly evolv­ing bio­phar­ma land­scape

10 months ago

How to safe­ly and suc­cess­ful­ly speed your in­jectable in­to the clin­ic

3 years ago

Are we clos­er than we think to per­son­al­ized ge­net­ic med­i­cine?

3 years ago

Avoid­ing Cell Ther­a­py Man­u­fac­tur­ing Grid­locks — a Do’s and Don’ts Guide

4 years ago

The four steps FU­JI­FILM Diosynth Biotech­nolo­gies is tak­ing to im­pact the fu­ture of bio­phar­ma man­u­fac­tur­ing

4 years ago

Lessons for biotech and phar­ma from a doc­tor who chased his own cure

6 years ago

The next 10 years: Where is biotech head­ed?

6 years ago

De­liv­er­ing CNS-fo­cused pa­tient in­no­va­tions

6 years ago
A service from the Financial Times